DEVICE CATEGORY · QVG
Embolization Agent, Vascular
For occluding peripheral vessels
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Embrace(TM) Hydrogel Embolic SystemP250003/S008 | Instylla, Inc. | PMA supplement | Oct 23, 2026 | FDA |
Embrace Hydrogel Embolic SystemP250003/S011 | Instylla, Inc. | PMA supplement | Oct 23, 2026 | FDA |
Embrace(TM) Hydrogel Embolic SystemP250003/S010 | Instylla, Inc. | PMA supplement | Oct 21, 2026 | FDA |
Embrace Hydrogel Embolic SystemP250003/S009 | Instylla, Inc. | PMA supplement | Sep 3, 2026 | FDA |
| Instylla, Inc. | PMA approval | Aug 5, 2025 | FDA |
Source information
Follow the FDA links to view the original records.


